This inventor holds 22 USPTO granted patents, primarily in Cholesterol Diagnostics. Top assignees: Boehringer Mannheim Gmbh, Roche Diagnostics Gmbh. Active years: 1978-2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Morlenbach, DE (1986)
- Peissenberg, DE (1978 - 1992)
- Rimbach-Zolzenbach, DE (1993)
- Rimbach-Zotzenbach, DE (1987 - 2001)
- Rimbach, DE (2007)
Company Filing History:
Years Active: 1978-2007
Areas of Expertise:
Title: Ulfert Deneke: Innovating Cholesterol Determination Methods
Introduction
Ulfert Deneke, an accomplished inventor based in Rimbach-Zotzenbach, Germany, has made significant contributions to the field of biomedical diagnostics, holding a remarkable total of 22 patents. His innovations focus primarily on methods and apparatuses for determining various cholesterol levels in biological fluid samples.
Latest Patents
Deneke's latest contributions include two notable patents. The first patent describes a method for the determination of HDL cholesterol using a rapid diagnostic agent with an integrated fractionating step. This apparatus features a first and second porous carrier, designed specifically for evaluating biological fluid samples. It effectively separates non-high-density lipoprotein (non-HDL) from a body sample and enables the determination of high-density lipoprotein (HDL) cholesterol.
The second patent details a method for separating non-HDLs from HDLs and determining HDL cholesterol. This invention employs a carrier that allows liquids to flow through it, incorporating a precipitating agent that targets non-high-density lipoproteins (non-HDLs) in biological fluids.
Career Highlights
Throughout his impressive career, Ulfert Deneke has worked with reputable companies in the biotechnology and diagnostics sectors. Notably, he has been associated with Boehringer Mannheim GmbH and Roche Diagnostics GmbH. These affiliations have provided him with a solid platform to develop his innovative techniques and patents in cholesterol determination.
Collaborations
Deneke has collaborated with esteemed professionals in his field, including Walter Rittersdorf and Hartmut Merdes. These partnerships have undoubtedly played a crucial role in the development and refinement of his patented technologies, further enhancing their efficacy and application in the medical diagnostics industry.
Conclusion
Ulfert Deneke's substantial patent portfolio and his innovative methods for cholesterol determination mark him as a significant figure in the field of biomedical diagnostics. His work not only contributes to advancements in medical technology but also improves the accuracy of cholesterol assessments, ultimately promoting better health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile